Cmed Clinical Services (Cmed CS) is a unique CRO which provides clinical services to drug development organisations world-wide.
Through the coupling of our own proprietary e-clinical technology, Timaeus, with our study delivery teams, Cmed CS has distinctive capabilities which enable us to deliver clinical projects innovatively; faster and more cost effectively.
Our unique abilities position Cmed CS ideally to provide a solution to the existing industry challenge of reaching the go / no-go decision efficiently, prior to phase III, via better planning and enhanced delivery of standard and complex early phase (I to IIb) clinical projects.
Our solution has also proven to help biotechnology organisations deliver early phase (I to IIb) clinical trials better (faster and more cost effectively) allowing them to gather the data required for potential partnering more efficiently.
Our vision is to provide our unique capabilities to customers so they can collect the right data at the right time in order to make the right decision.